Abiomed Team Demonstrates Impella at TCT 2015

October 14, 2015

As part of our coverage and participation at this year’s TCT Conference, our employees are actively demonstrating the Impella catheter and how it can help elective and urgent high risk PCI patients that are hemodynamically stable presenting with severe coronary artery disease and depressed ejection fraction. Watch each short video below for more information.

Impella 2.5 Silicone Vascular Model Demonstration

Jo, a national trainer for Abiomed, demonstrates how the Impella catheter is placed into the heart. The demonstration uses a see-through silicone model, and the Impella catheter can be seen going into the aorta and across the aortic valve for correct placement. Physicians who learn to place the Impella catheter into the heart use similar models for training.

Impella 2.5 Placement Simulation

Jessica, the national nurse educator for Abiomed, explains the placement of the Impella catheter using fluoroscopy. She shows the effects of Impella placement on cardiac wave forms and blood pressures. The video demonstrates the hemodynamic changes that occur when hemodynamic support is provided by the Impella catheter-based heart pump.


About Impella

The Impella 2.5 system is a temporary (<6 hours) ventricular support device indicated for use during high risk percutaneous coronary interventions (PCI) performed in elective or urgent, hemodynamically stable patients with severe coronary artery disease and depressed left ventricular ejection fraction, when a heart team, including a cardiac surgeon, has determined high risk PCI is the appropriate therapeutic option. Use of the Impella 2.5 in these patients may prevent hemodynamic instability which can result from repeat episodes of reversible myocardial ischemia that occur during planned temporary coronary occlusions and may reduce peri- and post-procedural adverse events.

Protected PCI and use of the Impella 2.5 is not right for every patient. Patients may not be able to be treated with Impella if they have certain pre-existing conditions, which a cardiologist can determine, such as: severe narrowing of the heart valve, severe peripheral artery disease, clots in blood vessels, or a replacement heart valve or certain heart valve deficiencies. Additionally, use of Impella has been associated with risks, including, but not limited to valvular and vascular injury, bleeding, and limb ischemia in certain patients. Learn more about the Impella devices’ approved indications for use, as well as important safety and risk information at www.protectedpci.com/hcp/information/isi.